Search

everythinglearnresearchcommunity

for

Search:↓

Dengue is more severe in children than adults, with higher risks of serious complications and death.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Face-lifts can lead to complications like bleeding, nerve injury, skin death, hair loss, and rare infections, with careful surgery reducing risks.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

A man experienced skin death after a hair transplant, likely due to poor blood supply related to his smoking habit.

Alopecia patients have a higher risk of heart disease.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

A patient had skin tissue death at the hair removal site after a hair transplant, which was treated with surgery.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

Oral minoxidil may have more cardiovascular risks than topical minoxidil.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.

The reported treatment depths were likely incorrect and could risk patient safety.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

Asian immigrant mothers in Leicestershire need better obstetric care to reduce higher perinatal mortality risks.

Milk can carry harmful plant toxins that pose health risks to animals and humans.

Werner's syndrome causes early aging and increases cancer risk, requiring early diagnosis and symptom management.

Accidental minoxidil exposure can cause serious illness or death in pets.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

Smoking and long surgeries can cause severe complications like tissue death after hair transplants.

Patients with multiple superficial venous thrombosis are at greater risk for serious complications like cancer and recurrent blood clots.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.